Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-29 Purchase(A) |
2021-08-04 4:41 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
1,625,000 | $8 | $13,000,000 | 2,234,752 (Indirect Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:12 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
125,000 | $8 | $1,000,000 | 125,000 (Indirect) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:11 pm |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
10,000 | $8 | $80,000 | 10,000 (Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:09 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
25,000 | $8 | $200,000 | 25,000 (Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:06 pm |
Candel Therapeutics Inc. | CADL | Canepa John J Chief Financial Officer |
10,125 | $8 | $81,000 | 10,125 (Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:02 pm |
Candel Therapeutics Inc. | CADL | Caffo Nathan Chief Business Officer |
6,000 | $8 | $48,000 | 6,000 (Direct) |
View |
| 2021-07-27 Purchase |
2021-07-29 9:02 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
56,000 | $7.3353 | $410,778 | 56,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-02-14 4:37 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
0 | $0 | 2,877,158 (Indirect) |
View |
| 2021-07-14 Ownership |
2022-02-14 4:37 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
36,752 | $0 | 2,877,158 (Indirect) |
View |
| 2022-02-03 Option Award |
2022-02-07 5:40 pm |
N/A 2032-02-03 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2022-02-07 5:35 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
0 | $0 | 50,322 (Direct) |
View |
| 2021-07-29 Conversion(A) |
2021-08-04 4:41 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
4,263,282 | $0 | 2,234,752 (Indirect) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:12 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
980,365 | $0 | 125,000 (Indirect) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:12 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer |
560,656 | $0 | 3,090,865 (Direct) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:08 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
4,263,282 | $0 | 609,752 (Indirect) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:04 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar Laura K. Chief Medical Officer |
193,977 | $0 | 2,944,139 (Direct) |
View |
Ownership |
2021-07-26 9:26 pm |
N/A 2030-12-14 |
Candel Therapeutics Inc. | CADL | Canepa John J Chief Financial Officer |
0 | $0 | 322,710 (Direct) |
View |
Ownership |
2021-07-26 9:26 pm |
N/A 2030-12-29 |
Candel Therapeutics Inc. | CADL | Stewart Susan B. Chief Regulatory Officer |
0 | $0 | 33,419 (Direct) |
View |
Ownership |
2021-07-26 9:25 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Meirav Udi Director |
0 | $0 | 164,773 (Direct) |
View |
Ownership |
2021-07-26 9:24 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | SMITH ALAN E Director |
0 | $0 | 69,164 (Direct) |
View |
Ownership |
2021-07-26 9:24 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
0 | $0 | 2,465,820 (Indirect) |
View |
Ownership |
2021-07-26 9:24 pm |
N/A 2027-04-05 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
0 | $0 | 69,164 (Direct) |
View |
Ownership |
2021-07-26 9:22 pm |
N/A 2030-10-09 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter President & CEO |
0 | $0 | 2,073,012 (Direct) |
View |
Ownership |
2021-07-26 9:22 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar Laura K. Chief Medical Officer |
0 | $0 | 3,038,757 (Direct) |
View |
Ownership |
2021-07-26 9:21 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer |
0 | $0 | 3,179,787 (Direct) |
View |
Ownership |
2021-07-26 9:20 pm |
N/A 2030-12-29 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
0 | $0 | 599,576 (Direct) |
View |
Ownership |
2021-07-26 9:18 pm |
N/A 2030-10-09 |
Candel Therapeutics Inc. | CADL | Caffo Nathan Chief Business Officer |
0 | $0 | 296,144 (Direct) |
View |